For the quarter ending 2025-09-30, BUSE had -$366,878K decrease in cash & cash equivalents over the period. $54,480K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 57,098 | 17,414 |
| Provision for credit losses | -985 | 51,293 |
| Amortization of intangible assets | 4,507 | 7,675 |
| Amortization of mortgage servicing rights | 159 | 327 |
| Depreciation and amortization of premises and equipment | 3,423 | 6,082 |
| Net amortization (accretion) on portfolio loans | 4,721 | 7,325 |
| Net amortization (accretion) of premium (discount) on investment securities | 46 | -1,451 |
| Net amortization (accretion) of premium (discount) on time deposits | 135 | 1,580 |
| Net amortization (accretion) of premium (discount) on fhlb advances and other borrowings | 470 | 1,000 |
| Impairment of oreo and other repossessed assets | 0 | 270 |
| Impairment of fixed assets held for sale | 0 | 188 |
| Impairment of mortgage servicing rights | 37 | -2 |
| Impairment of leases | 28 | - |
| Unrealized (gains) losses recognized on equity securities, net | -275 | 5,765 |
| (gain) loss on sales of debt securities, net | -13 | -15,536 |
| (gain) loss on sales of mortgage servicing rights | 0 | 0 |
| (gain) loss on sales of loans, net | 485 | 655 |
| (gain) loss on sales of oreo and other repossessed assets | -11 | -85 |
| (gain) loss on sales of premises and equipment | 22 | -49 |
| (gain) loss on life insurance proceeds | 0 | 357 |
| (increase) decrease in cash surrender value of bank owned life insurance | 1,623 | 2,834 |
| Provision for deferred income taxes | -915 | -2,217 |
| Stock-based compensation | 4,298 | 8,827 |
| Proceeds from the sale of mortgage servicing rights | 0 | 0 |
| Mortgage loans originated for sale | 31,474 | 45,736 |
| Proceeds from sales of mortgage loans | 33,459 | 39,639 |
| (increase) decrease in other assets | -2,417 | 3,754 |
| Increase (decrease) in other liabilities | -5,133 | -26,151 |
| Net cash provided by (used in) operating activities | 62,486 | 57,894 |
| Purchases of equity securities | 50 | 869 |
| Purchases of debt securities available for sale | 8,859 | 376,552 |
| Proceeds from sales of equity securities | 14 | 6,430 |
| Proceeds from sales of debt securities available for sale | 820 | 528,940 |
| Proceeds from paydowns and maturities of debt securities held to maturity | 18,690 | 24,719 |
| Proceeds from paydowns and maturities of debt securities available for sale | 151,428 | 202,613 |
| Purchases of restricted bank stock | 13 | 35,265 |
| Proceeds from the redemption of restricted bank stock | 119 | 11,786 |
| Net (increase) decrease in loans | -200,889 | 39,614 |
| Net cash received in (paid for) acquisitions (see note 2) | 0 | -385,804 |
| Cash paid for premiums on bank-owned life insurance | 0 | 46 |
| Proceeds from life insurance | 0 | 4,334 |
| Purchases of premises and equipment | 8,006 | 5,173 |
| Proceeds from disposition of premises and equipment | 708 | 2 |
| Capitalized expenditures on foreclosed real estate | 0 | 316 |
| Proceeds from sales of oreo and other repossessed assets, including cash payments collected | 965 | 15,611 |
| Net cash provided by (used in) investing activities | 356,705 | 722,404 |
| Net increase (decrease) in deposits | -731,475 | -750,837 |
| Proceeds from the exercise of stock options, warrants, and ssars | - | -364 |
| Net increase (decrease) in federal funds purchased and securities sold under agreements to repurchase | -10,878 | 2,420 |
| Repayment of short-term borrowings | 0 | -11,158 |
| Proceeds from other borrowings, net of debt issuance costs | 0 | 16,667 |
| Repayment of other borrowings | 99 | 125,030 |
| Cash dividends paid | 27,438 | 36,821 |
| Purchase of treasury stock | 13,547 | 26,491 |
| Cash paid for withholding taxes on stock-based payments | 3,002 | 1,547 |
| Cash paid for the exercise of stock options, warrants, and ssars | -452 | - |
| Issuance of treasury stock for the espp | 458 | 1,029 |
| Issuance of preferred stock, net of stock issuance costs | 0 | 207,447 |
| Common stock issuance costs | 0 | 920 |
| Net cash provided by (used in) financing activities | -786,069 | -725,605 |
| Net increase (decrease) in cash and cash equivalents | -366,878 | 54,693 |
| Cash and cash equivalents at beginning of period | 697,659 | - |
| Cash and cash equivalents at end of period | 385,474 | - |
FIRST BUSEY CORP NV (BUSE)
FIRST BUSEY CORP NV (BUSE)